| Sonal Bordia, | |
|
2130 Millburn Ave, Maplewood, NJ 07040-3725 | |
| (201) 936-6032 | |
| Not Available |
| Full Name | Sonal Bordia |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 2130 Millburn Ave, Maplewood, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346421781 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 260433 (New York) | Secondary |
| 207RH0003X | Internal Medicine - Hematology & Oncology | 25MA08928200 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sonal Bordia, 444 Washington Blvd Apt 6544, Jersey City, NJ 07310-1907 Ph: () - | Sonal Bordia, 2130 Millburn Ave, Maplewood, NJ 07040-3725 Ph: (201) 936-6032 |
News Archive
Scientists at Scripps Research have unveiled a new Ebola virus vaccine design, which they say has several advantages over standard vaccine approaches for Ebola and related viruses that continue to threaten global health.
University of Toronto and McGill University scientists are leading an international partnership to discover new and improved drug treatments for tuberculosis, malaria and neglected tropical diseases - thanks to a contribution from Merck Canada Inc., as well as an additional $5 million supplement to a grant from the Bill & Melinda Gates Foundation.
AMAG Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today reported unaudited consolidated financial results for the third quarter and nine months ended September 30, 2009.
Last week, FDA was notified that a Canadian research group stopped a study on Trasylol because the drug appeared to increase the risk for death compared to the other antifibrinolytic drugs used in the study. Antifibrinolytic drugs help slow the breakdown of blood clots and subsequent excessive bleeding.
Alcon, Inc. reported that global sales rose 14.5 percent to $1.72 billion for the fourth quarter of 2009, or an 8.5 percent increase excluding the impact of foreign exchange fluctuations. Reported net earnings for the fourth quarter of 2009 grew 8.0 percent to $458 million, or $1.51 per diluted share.
› Verified 9 days ago
Dr. Samuel T Duncan, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2040 Millburn Ave, Suite 303, Maplewood, NJ 07040 Phone: 973-762-4996 Fax: 973-762-4955 | |
Shailender Karry Mohanrao, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2115 Millburn Ave, Suite L2, Maplewood, NJ 07040 Phone: 973-275-1322 Fax: 973-900-8917 | |
Dr. Segun V Simon, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2130 Millburn Ave, Suite C-3, Maplewood, NJ 07040 Phone: 973-996-2727 Fax: 973-763-2558 | |
Shirish C Patrawalla, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 264 Boyden Ave, Maplewood, NJ 07040 Phone: 973-763-4120 Fax: 973-763-1713 | |
Sunil Patel, M.D Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2010 Springfield Ave, Maplewood, NJ 07040 Phone: 973-275-9500 Fax: 973-275-9501 | |
Dr. Khalil Ahmed Kaid, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2168 Millburn Ave, Suite 204, Maplewood, NJ 07040 Phone: 973-762-3353 Fax: 973-762-3370 | |
Dr. Arvind K Grover, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2168 Millburn Ave, Maplewood, NJ 07040 Phone: 973-763-5765 Fax: 973-763-0505 |